CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 1 - 10 of 819
Study Number Lead Group Study Title CIRB Study Status
S1400ANCILLARY SWOG Ancillary Study to Evaluate Patient and Physician Attitudes; Knowledge; and Expectations Related to Return of Genomic Results in Cancer in the SWOG 1400 (S1400) Clinical Trial Adult CIRB - Late Phase Emphasis
WF-1801 NCORP-Wake Forest University A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy Cancer Prevention and Control CIRB Available to Open
ALTE03N1 COG Key Adverse Events after Childhood Cancer Pediatric CIRB Available to Open
10264 ETCTN The PRIME Trial: PARP Inhibition in IDH Mutant Effectiveness Trial. A Phase II Study of Olaparib in Isocitrate Dehydrogenase (IDH) Mutant Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome Adult CIRB - Early Phase Emphasis Available to Open
10329 ETCTN Phase I Sequential Trial of Agents Against DNA Repair (STAR) Adult CIRB - Early Phase Emphasis Available to Open
10015 ETCTN A Non-Randomized; Open-Label; Phase 2 Study of Trametinib in Patients with Unresectable or Metastatic Epithelioid Hemangioendothelioma Adult CIRB - Early Phase Emphasis Available to Open
S1513 SWOG Randomized Phase II Study of 2nd Line FOLFIRI Versus Modified FOLFIRI with PARP Inhibitor ABT-888 (Veliparib) (NSC-737664) in Metastatic Pancreatic Cancer Adult CIRB - Late Phase Emphasis Available to Open
NWU2015-06-02 CLO-Northwestern University Immunogenicity of Nonavalent HPV Vaccine Administered Prior To Living Donor Renal Transplantation in Adult Women: A Prospective, Single-Arm, Multi-Center Clinical Trial Cancer Prevention and Control CIRB Available to Open
A221505 Alliance Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation with Breast Reconstruction Cancer Prevention and Control CIRB Available to Open
AOST1521 COG A Phase 2 Study of GPNMB-targeted Antibody-Drug Conjugate; CDX-011 (Glembatumumab Vedotin; CR011-vcMMAE; IND# 128248; NSC# 763737); in Recurrent or Refractory Osteosarcoma Pediatric CIRB Available to Open
Displaying 1 - 10 of 819